Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature.
RNF213 p.R4810K variant
East Asian
European Caucasian
Histopathology
Moyamoya disease
Southeast Asian
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
13 Mar 2024
13 Mar 2024
Historique:
received:
27
12
2023
accepted:
27
01
2024
revised:
27
01
2024
medline:
13
3
2024
pubmed:
13
3
2024
entrez:
13
3
2024
Statut:
aheadofprint
Résumé
Moyamoya disease (MMD) is a rare disorder causing ischemic and hemorrhagic juvenile stroke. It is associated with the founder susceptibility variant p.R4810K in the RNF213 gene in East Asia. Our aim was to enhance understanding of MMD in so far poorly characterized Southeast Asians and exploring differences with Caucasian Europeans. By retrospective analysis of medical records and systematic database search on PubMed for all published cases, we identified Southeast Asian patients with MMD. We extracted and pooled proportions using fixed-effects models. Our own cohort was tested for the East Asian RNF213 founder variant p.R4810K. One of our Southeast Asian patients underwent post-mortem histopathological examination. The study cohort comprised 32 Southeast Asians. Mean age at onset in the entire cohort was 32.5 ± 20.3 years (n = 24), 43.4 ± 8.7 years in patients admitted to our center (n = 11), and 23.4 ± 22.4 years in patients from the international literature (n = 13). Female-to-male ratio was 1.6:1. MMD predominantly affected bilateral anterior intracranial vessels. Cerebral ischemia outnumbered transient ischemic attacks (TIAs) and intracranial hemorrhage. TIAs, arterial hypertension and obesity were significantly less frequent in Southeast Asian patients compared to Caucasian Europeans. p.R4810K was absent in all examined Southeast Asians despite of typical histopathological signs of MMD in one autopsy case. Clinical and histopathological manifestations of MMD in Southeast Asians are similar to those in Caucasian Europeans. The genotype of MMD in Southeast Asians differs from that of most East Asian patients.
Sections du résumé
BACKGROUND
BACKGROUND
Moyamoya disease (MMD) is a rare disorder causing ischemic and hemorrhagic juvenile stroke. It is associated with the founder susceptibility variant p.R4810K in the RNF213 gene in East Asia. Our aim was to enhance understanding of MMD in so far poorly characterized Southeast Asians and exploring differences with Caucasian Europeans.
METHODS
METHODS
By retrospective analysis of medical records and systematic database search on PubMed for all published cases, we identified Southeast Asian patients with MMD. We extracted and pooled proportions using fixed-effects models. Our own cohort was tested for the East Asian RNF213 founder variant p.R4810K. One of our Southeast Asian patients underwent post-mortem histopathological examination.
RESULTS
RESULTS
The study cohort comprised 32 Southeast Asians. Mean age at onset in the entire cohort was 32.5 ± 20.3 years (n = 24), 43.4 ± 8.7 years in patients admitted to our center (n = 11), and 23.4 ± 22.4 years in patients from the international literature (n = 13). Female-to-male ratio was 1.6:1. MMD predominantly affected bilateral anterior intracranial vessels. Cerebral ischemia outnumbered transient ischemic attacks (TIAs) and intracranial hemorrhage. TIAs, arterial hypertension and obesity were significantly less frequent in Southeast Asian patients compared to Caucasian Europeans. p.R4810K was absent in all examined Southeast Asians despite of typical histopathological signs of MMD in one autopsy case.
CONCLUSION
CONCLUSIONS
Clinical and histopathological manifestations of MMD in Southeast Asians are similar to those in Caucasian Europeans. The genotype of MMD in Southeast Asians differs from that of most East Asian patients.
Identifiants
pubmed: 38478032
doi: 10.1007/s00415-024-12228-0
pii: 10.1007/s00415-024-12228-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases (2012) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52:245–266. https://doi.org/10.2176/nmc.52.245
doi: 10.2176/nmc.52.245
Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226–1237. https://doi.org/10.1056/NEJMra0804622
doi: 10.1056/NEJMra0804622
pubmed: 19297575
Mertens R, Graupera M, Gerhardt H et al (2022) The genetic basis of moyamoya disease. Transl Stroke Res 13:25–45. https://doi.org/10.1007/s12975-021-00940-2
doi: 10.1007/s12975-021-00940-2
pubmed: 34529262
Baba T, Houkin K, Kuroda S (2008) Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900–904. https://doi.org/10.1136/jnnp.2007.130666
doi: 10.1136/jnnp.2007.130666
pubmed: 18077479
Ahn IM, Park D-H, Hann HJ et al (2014) Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke 45:1090–1095. https://doi.org/10.1161/STROKEAHA.113.004273
doi: 10.1161/STROKEAHA.113.004273
pubmed: 24595588
Uchino K, Johnston SC, Becker KJ, Tirschwell DL (2005) Moyamoya disease in Washington State and California. Neurology 65:956–958. https://doi.org/10.1212/01.wnl.0000176066.33797.82
doi: 10.1212/01.wnl.0000176066.33797.82
pubmed: 16186547
Wang Y, Zhang Z, Wei L et al (2020) Predictive role of heterozygous p. R4810K of RNF213 in the phenotype of Chinese moyamoya disease. Neurology 94:e678–e686. https://doi.org/10.1212/WNL.0000000000008901
doi: 10.1212/WNL.0000000000008901
pubmed: 31949090
pmcid: 7176299
Liu W, Hitomi T, Kobayashi H et al (2012) Distribution of moyamoya disease susceptibility polymorphism p. R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo) 52:299–303. https://doi.org/10.2176/nmc.52.299
doi: 10.2176/nmc.52.299
pubmed: 22688066
Liu W, Hashikata H, Inoue K et al (2010) A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med 15:94–104. https://doi.org/10.1007/s12199-009-0116-7
doi: 10.1007/s12199-009-0116-7
pubmed: 19921495
Liu W, Morito D, Takashima S et al (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE 6:e22542. https://doi.org/10.1371/journal.pone.0022542
doi: 10.1371/journal.pone.0022542
pubmed: 21799892
pmcid: 3140517
Kraemer M, Keyvani K, Berlit P et al (2019) Histopathology of Moyamoya angiopathy in a European patient. J Neurol 266:2258–2262. https://doi.org/10.1007/s00415-019-09406-w
doi: 10.1007/s00415-019-09406-w
pubmed: 31165233
Kraemer M, Schwitalla JC, Diesner F et al (2019) Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients. J Neurol 266:1421–1428. https://doi.org/10.1007/s00415-019-09277-1
doi: 10.1007/s00415-019-09277-1
pubmed: 30868219
Bersano A, Khan N, Fuentes B et al (2023) European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: endorsed by Vascular European Reference Network (VASCERN). Eur Stroke J. https://doi.org/10.1177/23969873221144089
doi: 10.1177/23969873221144089
pubmed: 37021176
pmcid: 10069176
Kudo T (1968) Spontaneous occlusion of the circle of Willis. A disease apparently confined to Japanese. Neurology 18:485–496. https://doi.org/10.1212/wnl.18.5.485
doi: 10.1212/wnl.18.5.485
pubmed: 5691175
Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299. https://doi.org/10.1001/archneur.1969.00480090076012
doi: 10.1001/archneur.1969.00480090076012
pubmed: 5775283
Kuroda S, Fujimura M, Takahashi J et al (2022) Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version. Neurol Med Chir (Tokyo) 62:307–312. https://doi.org/10.2176/jns-nmc.2022-0072
doi: 10.2176/jns-nmc.2022-0072
pubmed: 35613882
Lubman DI, Pantelis C, Desmond P et al (2003) Moyamoya disease in a patient with schizophrenia. J Int Neuropsychol Soc JINS 9:806–810. https://doi.org/10.1017/S1355617703950132
doi: 10.1017/S1355617703950132
pubmed: 12901786
Khanjanasthiti P, Sukondhabhant S (1979) Moyamoya vessels. J Med Assoc Thail Chotmaihet Thangphaet 62:573–577
Dechakaisaya P (1979) Moyamoya disease. J Med Assoc Thail Chotmaihet Thangphaet 62:39–43
Phattranonuthai R, Frucht SJ, Termsarasab P (2020) Unilateral leg freezing in moyamoya syndrome. Parkinsonism Relat Disord 78:96–97. https://doi.org/10.1016/j.parkreldis.2020.06.024
doi: 10.1016/j.parkreldis.2020.06.024
pubmed: 32777536
Visudhiphan P, Chiemchanya S, Jenjitranant J, Charuvanij A (1989) Moyamoya disease: a report of four cases of Thai children. J Med Assoc Thail Chotmaihet Thangphaet 72(Suppl 1):109–115
Thampratankul L, Okuno Y, Komvilaisak P, et al (2022) Identification of Alpha Thalassemia, RNF213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome. Mediterr J Hematol Infect Dis 14:e2022057. https://doi.org/10.4084/MJHID.2022.057
Visrutaratna P, Srisuwan T, Sirivanichai C (2009) Pediatric renovascular hypertension in Thailand: CT angiographic findings. Pediatr Radiol 39:1321–1326. https://doi.org/10.1007/s00247-009-1380-9
doi: 10.1007/s00247-009-1380-9
pubmed: 19685045
Tan E-K, Chan L-L, Yu GX et al (2003) Vascular parkinsonism in moyamoya: microvascular biopsy and imaging correlates. Ann Neurol 54:836–840. https://doi.org/10.1002/ana.10783
doi: 10.1002/ana.10783
pubmed: 14681896
Bolem N, Nga VDW, Chou N et al (2020) Coexisting moyamoya syndrome and type 1 diabetes mellitus: a case report and review of the literature. Asian J Neurosurg 15:194–197. https://doi.org/10.4103/ajns.AJNS_218_19
doi: 10.4103/ajns.AJNS_218_19
pubmed: 32181202
pmcid: 7057905
Ng WK, Tan CT, George J et al (1995) Moyamoya disease in Malaysia: two documented cases. Med J Malaysia 50:186–188
pubmed: 7565194
Sharma A, Soneji N, Farah G (2014) Clinical and angiographic findings in Moya Moya. Am J Case Rep. 15:147–151. https://doi.org/10.12659/AJCR.890222
doi: 10.12659/AJCR.890222
pubmed: 24753782
pmcid: 3992217
Gunawan P, Suryaningtyas W, Saharso D, Prasetyo R (2017) Combination of Encephalo-Myo-Pial-Synangiosis and Encephalo-Arterio-Pial-Synangiosis Procedure in Pediatric Moya-Moya Disease. Ethiop J Health Sci 27:193–196. https://doi.org/10.4314/ejhs.v27i2.12
doi: 10.4314/ejhs.v27i2.12
pubmed: 28579715
pmcid: 5440834
Pilgram-Pastor S, Chapot R, Kraemer M (2022) The angiographic presentation of European Moyamoya angiopathy. J Neurol 269:997–1006. https://doi.org/10.1007/s00415-021-10684-6
doi: 10.1007/s00415-021-10684-6
pubmed: 34240321
Khan N, Achrol AS, Guzman R et al (2012) Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery 71:587–593. https://doi.org/10.1227/NEU.0b013e3182600b3c . (Discussion 593)
doi: 10.1227/NEU.0b013e3182600b3c
pubmed: 22718024
Hever P, Alamri A, Tolias C (2015) Moyamoya angiopathy—is there a Western phenotype? Br J Neurosurg 29:765–771. https://doi.org/10.3109/02688697.2015.1096902
doi: 10.3109/02688697.2015.1096902
pubmed: 26473792
Miller R, Unda SR, Holland R, Altschul DJ (2021) Western moyamoya phenotype: a scoping review. Cureus 13:e19812. https://doi.org/10.7759/cureus.19812
doi: 10.7759/cureus.19812
pubmed: 34956795
pmcid: 8693830
Liu W, Senevirathna STMLD, Hitomi T et al (2013) Genomewide association study identifies no major founder variant in Caucasian moyamoya disease. J Genet 92:605–609. https://doi.org/10.1007/s12041-013-0304-5
doi: 10.1007/s12041-013-0304-5
pubmed: 24371184
Wiedmann MKH, Steinsvåg IV, Dinh T et al (2023) Whole-exome sequencing in moyamoya patients of Northern-European origin identifies gene variants involved in Nitric Oxide metabolism: a pilot study. Brain Spine 3:101745. https://doi.org/10.1016/j.bas.2023.101745
doi: 10.1016/j.bas.2023.101745
pubmed: 37383439
pmcid: 10293314
Kuroda S, Yamamoto S, Funaki T et al (2023) Five-year stroke risk and its predictors in asymptomatic moyamoya disease: Asymptomatic Moyamoya Registry (AMORE). Stroke 54:1494–1504. https://doi.org/10.1161/STROKEAHA.122.041932
doi: 10.1161/STROKEAHA.122.041932
pubmed: 37216455
National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Health and Medicine Division; Committee on Population; Board on Health Sciences Policy; Committee on the Use of Race, Ethnicity, and Ancestry as Population Descriptors in Genomics Research (2023) Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field. National Academies Press (US), Washington (DC).
Goto Y, Yonekawa Y (1992) Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 32:883–886. https://doi.org/10.2176/nmc.32.883
doi: 10.2176/nmc.32.883
pubmed: 1282678
Sato Y, Kazumata K, Nakatani E et al (2019) Characteristics of moyamoya disease based on National Registry Data in Japan. Stroke 50:1973–1980. https://doi.org/10.1161/STROKEAHA.119.024689
doi: 10.1161/STROKEAHA.119.024689
pubmed: 31234758
Hoshino H, Izawa Y, Suzuki N, Research Committee on Moyamoya Disease (2012) Epidemiological features of moyamoya disease in Japan. Neurol Med Chir (Tokyo). 52:295–298. https://doi.org/10.2176/nmc.52.295
doi: 10.2176/nmc.52.295
pubmed: 22688065
Po’ C, Nosadini M, Zedde M, et al (2022) Pediatric moyamoya disease and syndrome in Italy: a multicenter cohort. Front Pediatr 10:892445. https://doi.org/10.3389/fped.2022.892445
doi: 10.3389/fped.2022.892445
pubmed: 35601411
Acker G, Goerdes S, Schneider UC et al (2015) Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians. Eur J Neurol 22:1012–1017. https://doi.org/10.1111/ene.12702
doi: 10.1111/ene.12702
pubmed: 25847099
Bersano A, Bedini G, Nava S et al (2019) GEN-O-MA project: an Italian network studying clinical course and pathogenic pathways of moyamoya disease-study protocol and preliminary results. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 40:561–570. https://doi.org/10.1007/s10072-018-3664-z
doi: 10.1007/s10072-018-3664-z
Birkeland P, Tharmabalan V, Lauritsen J et al (2020) Moyamoya disease in a European setting: a Danish population-based study. Eur J Neurol 27:2446–2452. https://doi.org/10.1111/ene.14439
doi: 10.1111/ene.14439
pubmed: 32668488
Graf J, Schwitalla JC, Albrecht P et al (2019) Misdiagnoses and delay of diagnoses in Moyamoya angiopathy-a large Caucasian case series. J Neurol 266:1153–1159. https://doi.org/10.1007/s00415-019-09245-9
doi: 10.1007/s00415-019-09245-9
pubmed: 30805794
Takekawa Y, Umezawa T, Ueno Y et al (2004) Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathol Off J Jpn Soc Neuropathol 24:236–242. https://doi.org/10.1111/j.1440-1789.2004.00550.x
doi: 10.1111/j.1440-1789.2004.00550.x
Fukui M, Kono S, Sueishi K, Ikezaki K (2000) Moyamoya disease. Neuropathol Off J Jpn Soc Neuropathol 20(Suppl):S61-64. https://doi.org/10.1046/j.1440-1789.2000.00300.x
doi: 10.1046/j.1440-1789.2000.00300.x